You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinosarcoma

Showing 1 - 25 of 111
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Carcinosarcoma, Uterine Carcinosarcoma Trial (Eribulin Mesylate, Pembrolizumab)

Not yet recruiting
  • Ovarian Carcinosarcoma
  • Uterine Carcinosarcoma
  • (no location specified)
Jan 31, 2023

Gynecologic Cancer, Carcinoma, Uterine Cancer Trial in Birmingham (Cabo + Dostarlimab)

Not yet recruiting
  • Gynecologic Cancer
  • +3 more
  • Cabo + Dostarlimab
  • Birmingham, Alabama
    O'Neal Comprehensive Cancer Center at UAB
Jan 10, 2023

Recurrent/Metastatic Carcinosarcoma Trial in Seoul (nivolumab)

Recruiting
  • Recurrent/Metastatic Carcinosarcoma
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Feb 3, 2022

Uterine Cancer Trial in Boston (AZD1775)

Recruiting
  • Uterine Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 5, 2022

PD-1 Immunotherapy, VEGFR-TKI, Sarcomatoid Carcinoma Trial in Shanghai (Camrelizumab Combined With Apatinib)

Recruiting
  • PD-1 Immunotherapy
  • +3 more
  • Camrelizumab Combined With Apatinib
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 1, 2022

Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

Not yet recruiting
  • Advanced Solid Tumor
  • +15 more
  • (no location specified)
Jun 2, 2023

Breast Carcinoma, Endometrial Carcinoma, Prostate Carcinosarcoma Trial in Philadelphia (dietary supplement, other, procedure)

Completed
  • Breast Carcinoma
  • +2 more
  • Dietary Intervention
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Jan 4, 2023

Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma, Recurrent Fallopian Tube Carcinoma Trial in Rochester (Biopsy,

Not yet recruiting
  • Fallopian Tube Carcinosarcoma
  • +14 more
  • Biopsy
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 28, 2023

Uterine Carcinosarcoma, Advanced Uterine Carcinosarcoma Trial in United States (Pembrolizumab, Lenvatinib)

Recruiting
  • Uterine Carcinosarcoma
  • Advanced Uterine Carcinosarcoma
  • Basking Ridge, New Jersey
  • +6 more
Apr 27, 2022

Endometrial Cancer, Endometrial Carcinosarcoma, Endometrial Carcinoma Trial in United States (Durvalumab, Tremelimumab)

Completed
  • Endometrial Cancer
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2023

Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic

Terminated
  • Ovarian Cancer
  • +21 more
  • Exercise Counseling
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 6, 2022

Endometrial Carcinosarcoma Trial in United States (Pembrolizumab, Olaparib)

Recruiting
  • Endometrial Carcinosarcoma
  • Basking Ridge, New Jersey
  • +6 more
Mar 17, 2022

Ovarian Carcinosarcoma, Endometrial Carcinosarcoma Trial in France (Niraparib, Niraparib + TSR-042 (Dostarlimab), Chemotherapy

Recruiting
  • Ovarian Carcinosarcoma
  • Endometrial Carcinosarcoma
  • Angers, France
  • +19 more
Feb 23, 2022

Ovarian Cancer, Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial (Pamiparib, Surufatinib)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • (no location specified)
Aug 8, 2022

Carcinosarcoma, Ovarian Trial in Oklahoma City (Galunisertib, Paclitaxel, Carboplatin)

Active, not recruiting
  • Carcinosarcoma, Ovarian
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center, University of Oklahoma Health Sciences
Sep 27, 2021

Carcinosarcoma, Ovarian, Carcinosarcomas Uterine Trial in Rome (Trabectedin)

Completed
  • Carcinosarcoma, Ovarian
  • Carcinosarcomas Uterine
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Aug 24, 2021

Esophageal Tumor, Adenocarcinoma of the Gastroesophageal Junction, GastroEsophageal Cancer Trial in United States (DKN-01)

Available
  • Esophageal Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +3 more
Aug 24, 2022

Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

Recruiting
  • Cervical Adenocarcinoma
  • +47 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +3 more
Dec 5, 2022

Electrical Impedance Spectroscopy for Early Diagnosis of Skin

Suspended
  • Melanoma (Skin)
  • +7 more
  • Electrical Impedence Spectroscopy DermaSense
  • Thessaloniki, Greece
    Laboratory of Medical Physics, AUTH
Apr 4, 2022

Liquid Biopsies and Tumor Molecular Profiling in Predicting

Recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +5 more
  • Biospecimen Collection
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 3, 2022

Investigate Adaptation and Evolution of Ovarian High-grade

Recruiting
  • Ovarian Cancer
  • +6 more
    • Bristol, United Kingdom
    • +10 more
    Sep 8, 2022

    Ovarian Cancer, Ovarian Tumors, Ovarian Carcinosarcoma Trial in Germany, United Kingdom (Paclitaxel, TAK228)

    Active, not recruiting
    • Ovarian Cancer
    • +9 more
    • Berlin, Germany
    • +14 more
    Mar 10, 2022

    Endometrial Adenocarcinoma, Endometrial Carcinosarcoma Trial in United States (Nivolumab, BMS- 986205)

    Active, not recruiting
    • Endometrial Adenocarcinoma
    • Endometrial Carcinosarcoma
    • Basking Ridge, New Jersey
    • +6 more
    Nov 29, 2021

    Soft Tissue Sarcoma, Renal Cell Carcinoma, Uterine Carcinosarcoma Trial in United States (HFB301001)

    Recruiting
    • Soft Tissue Sarcoma
    • +4 more
    • Scottsdale, Arizona
    • +9 more
    Sep 13, 2022

    Ovarian Cancer, Carcinosarcoma Trial (Pamiparib)

    Withdrawn
    • Ovarian Cancer
    • Carcinosarcoma
    • (no location specified)
    Aug 3, 2021